middle.news
CLINUVEL Hits 200-Patient Mark in Pivotal Vitiligo Trial, Eyes 2026 Data
3:07am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
CLINUVEL Hits 200-Patient Mark in Pivotal Vitiligo Trial, Eyes 2026 Data
3:07am on Monday 2nd of June, 2025 AEST
Key Points
Full recruitment of 200 vitiligo patients achieved in Phase III CUV105 trial
Trial spans 37 sites across North America, Africa, and Europe
Treatment combines SCENESSE® with NB-UVB phototherapy or NB-UVB alone
First clinical case studies show encouraging repigmentation and tolerability
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE